Search Results
134 Results for 'Drug Discovery & Development'
PAGE 4 OF 6
Technology
New Viral Propagation Method Yields Insight Into Childhood Asthma
In addition to the common cold, human rhinoviruses (RV) trigger nearly half of all cases of asthma exacerbation. Wheezing illnesses in infancy caused by RV are associated with a high risk of developin...
Learn More
Learn More
James Gern, Yury Bochkov, Ann Palmenberg | P140382US02
Technology
Adapted Rhinovirus C for Maximum Virus Yield
Human rhinoviruses (species A, B and C) encompass more than 160 types that are responsible for the majority of upper respiratory tract infections (common colds) and many of the lower respiratory tract...
Learn More
Learn More
James Gern, Yury Bochkov, Ann Palmenberg, Kelly Watters | P160050US02
Technology
Better Living Through Peptides; Improved Approach to HIV Therapy
Human immunodeficiency virus (HIV) affects over 1.2 million Americans each year, with approximately 50,000 new infections per year. Current treatment includes HIV combination regimens comprising rever...
Learn More
Learn More
Samuel Gellman, William Horne, Lisa Johnson | P08414US03
Technology
New Target for Diagnosing, Treating Neurodegenerative Diseases
Amyotrophic lateral sclerosis (ALS) is a devastating disease with no effective treatment. In patients with ALS, the neurons in their brains degenerate, leading to cognitive and physical breakdown. Oth...
Learn More
Learn More
Su-Chun Zhang, Hong Chen | P140125US02
Technology
Increasing Red Blood Cell Production
Maintaining an adequate supply of oxygen to tissue is necessary for survival. The oxygen-carrying capacity of blood is governed by the concentration of red blood cells (erythrocytes). It is critical t...
Learn More
Learn More
Emery Bresnick, Yoon A Kang, Skye McIver | P130326US02
Technology
Improved Phage Display System Enables Screening of Liver-Specific Peptides
In vivo phage display is a protein library development and screening tool that has proven to be a powerful means of identifying new peptide ligands for specific targeting of organs by drugs and gene t...
Learn More
Learn More
Alexander Sokoloff, Jon Wolff, James Ludtke | P07196US
Technology
New System for Producing Fungal Secondary Metabolites
Fungi produce a variety of chemical compounds called secondary metabolites that possess useful pharmaceutical properties. These compounds are invaluable platforms for developing front-line drugs. They...
Learn More
Learn More
Nancy Keller, Philipp Wiemann | P150029US02
Technology
Ringworm Fungal Strain for Infection Studies
Microsporum canis is a skin fungal pathogen that causes dermatophytosis (ringworm) most commonly in cats and dogs. Dermatophytosis clinical trials are lengthy and complicated because the nature of the...
Learn More
Learn More
Douglas DeBoer, Karen Moriello | P140194US01
Technology
Peptide Mimics Last Longer, Target Protein-Protein Interactions
The ability to modulate interactions between proteins is an attractive goal for both research and therapeutic applications. Developing modulating agents using traditional small-molecule approaches is ...
Learn More
Learn More
Samuel Gellman, James Checco | P140148US02
Technology
Understanding and Treating Nervous System Dysfunction Using Modified Fly Models
Neurological disorders—ranging from spinal cord injuries to Alzheimer’s disease—are among the most challenging health issues. There is an ongoing need for disease models and screening systems to...
Learn More
Learn More
Barry Ganetzky, Daniel Miller, Shannon Ballard | P120334US02
Technology
Wisconsin Miniature SwineTM for Biomedical Research
Rodents and other small animals are extensively used as models to study human health and disease, but there are increasing concerns about their relevance. Research funding and regulatory agencies are ...
Learn More
Learn More
Jess Reed, Christian Krueger, Dhanansayan Shanmuganayagam, Thomas Crenshaw, Jamie Reichert, Joan Parrish | P130271US01
Technology
Wisconsin Miniature SwineTM for Cardiovascular Research
Rodents and other small animals are extensively used as models to study human health and disease, but there are increasing concerns about their relevance. Research funding and regulatory agencies are ...
Learn More
Learn More
Jess Reed, Christian Krueger, Dhanansayan Shanmuganayagam, Thomas Crenshaw, Jamie Reichert, Joan Parrish | P140228US01
Technology
Mouse Model for Mania
Presently, there are no good rodent models for mania, which is a critical component of bipolar disorder. The most commonly used approach is to inject normal mice with amphetamines to produce hyperacti...
Learn More
Learn More
Stephen Gammie | P100188US01
Technology
Laser Drilling Quartz to Make Patch Clamp Plate Arrays
Patch clamping is a well-known technique for investigating the movement of ions and molecules through cellular membranes via ion channels. To create an extremely high-resistance ‘gigaseal’ around ...
Learn More
Learn More
Robert Blick, Minrui Yu | P100021US01
Technology
Increasing Secondary Metabolite Production in Fungus for Drug Development
Fungi produce a variety of chemical compounds called secondary metabolites. These compounds display a broad range of activities, including fighting off other fungi and bacteria. They also are useful f...
Learn More
Learn More
Nancy Keller, Jin Woo Bok | P130203US01
Technology
Dramatically More Sensitive Ion Channel Antenna
Nearly half of all diseases involve ion channels – channels in cell membranes that control the flow of ions into and out of cells. Certain channels open in response to natural signal molecules as we...
Learn More
Learn More
Robert Blick, Abhishek Bhat | P130074US01
Technology
Enhanced Blood-Brain Barrier Model Outperforms All Others
The blood-brain barrier (BBB) is made up of brain microvascular endothelial cells (BMECs), which line brain capillaries and control trafficking between the bloodstream and neural tissue. Although esse...
Learn More
Learn More
Eric Shusta, Samira Azarin, Sean Palecek, Ethan Lippmann | P130017US02
Technology
Patch Clamp Providing On-Chip Thermal Control
Approximately half of all diseases affect the function of ion channels in cell membranes. Testing the flow of ions and molecules through these membranes clearly is vital to drug discovery and research...
Learn More
Learn More
Robert Blick | P110325US01
Technology
Easier, More Flexible Synthesis of Therapeutic and Promising Compounds
Many pharmaceuticals and other biologically active molecules contain chemical sequences called triads that are challenging to prepare in the laboratory. Specifically, triads are three or more contiguo...
Learn More
Learn More
Jennifer Schomaker, Luke Boralsky, John Hershberger, Jared Rigoli, Christopher Adams | P110299US02
Technology
Safer Influenza Vaccine from Replication-Knock Out Virus
Influenza viruses instigate annual global epidemics. The first influenza pandemic in 40 years occurred during the 2009-2010 season, when a novel H1N1 strain emerged and spread worldwide. The United St...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Makoto Ozawa | P110003US02
Technology
Improved Method to Produce Brain Microvascular Endothelial Cells for a Robust Human Blood-Brain Barrier Model
Although it is essential to healthy brain function, the blood-brain barrier (BBB) interferes with drug delivery, preventing more than 98 percent of small molecule pharmaceuticals and nearly 100 percen...
Learn More
Learn More
Eric Shusta, Samira Azarin, Sean Palecek, Ethan Lippmann | P100219US02
Technology
Diazaphosphacycles, Which Are Used to Catalyze Commercially Important Reactions, and Methods of Synthesis
Phosphines have many commercial and industrial uses as attachments to rare earth metal catalysts, including specialized uses in asymmetric hydrogenation and other catalytic transformations. Asymmetric...
Learn More
Learn More
Clark Landis, Wiechang Jin, Jonathan Owen, Thomas Clark, Ryan Nelson | P03130US
Technology
A Model for Familial Combined Hyperlipidemia and Type II Diabetes Mellitus
People with familial combined hyperlipidemia (FCH) are hypertriglyceridemic and hypercholesterolemic, and often go on to develop type II diabetes mellitus in middle age. Current FCH mouse models resul...
Learn More
Learn More
Lisa Krugner-Higby, Janice Wagner | P01090US
Technology
Library of Glycosylated Chlorambucil Analogs for Cancer Treatment
Many of the compounds used in drug discovery by pharmaceutical companies consist of a central core structure (aglycon) and various sugar (glycosyl) attachments. Because the sugar moieties of many of t...
Learn More
Learn More
Jon Thorson, Randal Goff | P110076US02
Technology
Targeted Disruption of the Murine NADPH Cytochrome P-450 Oxidoreductase Gene
Cytochrome P450 (CYP) is a family of predominantly hepatic enzymes known to be important in the metabolism of many drugs, carcinogens and other chemicals of pharmacologic and toxicologic significance....
Learn More
Learn More
Charles Kasper, Anna Lee Shen, Kathleen O'Leary | P01355US